Works CitedBalasekaran R. 2000 Feb 15. Positive results on tests for steatorrhea in persons consuming olestra potato chips. Annals of Internal Medicine. 132(4). 279-282. Banks P, Bartley W, Birt LM. 1976. The Biochemistry of the Tissues. 2 nd Ed. London: Wiley. Barlam TF, McCloud E. 2003 July. Sever Gastrointestinal illness associated with olestra ingestion. J. of Pediatric Gastroenterology & Nutr. 37(1). 95-96. Center for Science in the Public Interest. 2002 Apr 16. New Olestra Complaints Bring Total Close to 20,000 – More Than All Other Food Additive Complaints in History Combined. CSPI Newsroom. <http://www.cspinet.org/new/olestrapr_041602.html>. Accessed 2005 Sept 20. Cheskin LJ, Miday R, Zorich N, Filloon T. as cited in Jandacek et al. 1998. Gastrointestinal symptoms following consumption of olestra or regular triglyceride potato chips. JAMA. 279. 150-152. Clark SB, Lawergren B, Martin JV. as cited in Jandacek et al. 1973. Regional intestinal absorptive capacities for triolein: an alternative to markers. Am. J. Physiol. 225. 574-585. Cooper DA, et al. as cited in Jandacek et al. 1997. Olestra dose response on fat-soluble and water-soluble nutrients in the pig. J. Nutr. 127. 1573S-1588S. Cortot A, Phillips SF, Webb MR. as cited in Jandacek. 1982. Parallel gastric emptying of nonhydrolyzable fat and water after a solid-liquid meal in humans. Gastroenerology. 82. 877-881. Daher GC, et al. 1997. Olestra ingestion and dietary fat absorption in humans. J. Nutr. 127(8 Suppl.) 1694S-1698S. Federal Register, Part III, U.S. Department of Health and Human Services, Food and Drug Administration. as cited in Jandacek. 21 CFR Part 172, Food additives permitted for direct addition to food for human consumption: Olestra: Final rule. 62. 3118-3173. January 30, 1996. Forman LP, Schneeman BO. as cited in Jandacek. 1980. Effects of dietary pectin and fat on the small intestinal contents and exocrine pancrease of the rat. J. Nutr. 166. 1992-1999. Freston JW, et al. 1997 Oct. Review and analysis of the effects of Olestra, a dietary fat substitute, on gastrointestinal function and symptoms. Regul. Toxicol Pharmocol. 26(2). 210-218. Guyton AC. 1986. Textbook of Medical Physiology. 7 th Ed. Philadelphia: Saunders. Institute of Food Science & Technology. 2004 January. IFST Current Hot Topics: Olestra. <http://www.ifst.org/hottop13.htm>. Accessed 2005 Sept 20. Jandacek RJ, et al. 1999 Aug. Olestra formulation and the gastrointestinal tract. Lipids. 34(8). 771-783. Jandacek RJ, Ramirez MM, Crouse JR III. 1990. Effects of partial replacement of dietary fat by olestra on dietary cholesterol absorption in man. Metabolism: Clinical and Experimental. 39(8). 848-852. Levine J, et al. 2003 Apr. Author’s financial relationships with the food and beverage industry and their published positions on the fat substitute olestra. Am. J. of Public Health. 93(4). 664-669. Lovejoy M, et al. 2003 Oct. Consumption of a controlled low-fat diet containing olestra for 9 months improves health risk factors in conjunction with weight loss in obese men: the Ole Study. International J. of Obesity. 27(10). 1242-1247. McMurray WC. 1983. Essentials of Human Metabolism: the relationship of biochemistry to human physiology and disease. 2 nd Ed. Philadelphia: Harper and Row. McRorie J, Brown S, et al. 2000 Apr. Effects of dietary fibre and olestra in regional apparent viscosity and water content of digesta residue in porcine large intestine. Ailmentary Pharmocology & Theraputics. 14(4). 471-477. McRorie J, Kesler J, et al. 2000 May. Effects of wheat bran and olestra on objective measures of stool and subjective reports of GI symptoms. Am. J. of Gastroenterology. 95(5). 1244-1252. Moser GA, McLaughlan MS, Michael S. 1999 Oct. A non-absorbable dietary fat substitute enhances elimination of persistent lipophilic contaminants in humans. Chemosphere. 39(9). 1513-1521. Mountcastle VB. 1974. Medical Physiology. Saint Louis: C.V. Mosby Co. Nuck BA, Schlagheck TG, Federle TW. 1994. Inability of the human fecal microflora to metabolize the nonabsorbable fat substitute, olestra. J. of Industrial Microbiology. 13(5). 328-334. Patterson RE., et al. 2005 Sep 25. Changes in diet, weight, and serum lipid levels associated with olestra consumption. Archives of Internal Medicine. 160(17). 2600-2604. Peters JC, et al. 1997. Assessment of the nutritional effects of olestra, a nonabsorbed fat replacement. J. of Nutr. 127(8 Suppl.) 1719S-1728S. Procter & Gamble. 2000. Olean. <www.olean.com>. Accessed 2005 Sept 20. Rudolph C. 2000 May. Effects of what bran and olestra on objective measures of stool and subjective reports of GI symptoms. Am. J. of Gastroenterology. 95(5). 1244-1252. Siigur U, et al. as cited in Jandacek et al. 1996. Effect of olestra on faecal water and short-chain fatty acids. Microb. Ecol. Health Dis. 9. 9-17. Tsuji M, Saito N, Inoue, S. 2001 Nov. Inhibitors of absorption as anti-obesity drugs. Folia Pharmacologica Japonica. 118(5). 340-346. Tortora GJ. 1987. Principles of Anatomy and Physiology. 5 th Ed. New York: Harper and Row. Zorich NL, et al. as cited in Jandacek et al. 1997. Randomized, double-blind, placebo-controlled, consumer rechallenge test of olean salted snacks. Regul. Toxicol. Pharmacol. 26. 200-209.
|